What Is Research Telling Us About CXL in KC?

Developments in Transepithelial (“Epi-On”) CXL

To treat the earliest forms of keratoconus prior to significant vision loss, there needs to be a treatment method that significantly reduces procedure risk while achieving efficacy.

Read the full article here.

Next
Next

Keratoconus Treatment Clinical Study: Enrollment Deadline Ends Soon!